# Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy

**Authors:** Yousra Cheddadi, Mounir El Maï, Vesna Brglez, Sarah Nahon Carzo, Marion Cremoni, Maxime Teisseyre, Barbara Seitz-Polski

PMC · DOI: 10.1016/j.ekir.2026.106365 · Kidney International Reports · 2026-02-19

## Full-text entities

- **Diseases:** Membranous Nephropathy (MESH:D015433)
- **Chemicals:** Rituximab (MESH:D000069283)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13022648/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13022648/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC13022648/full.md

---
Source: https://tomesphere.com/paper/PMC13022648